Mohamed Wa'el Ahmed Hashad
Chief Executive Officer at Longeveron Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2024
6 years of board service in total across 2 boards, counting each seat separately. Longest: Akari Therapeutics plc, 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 2025 | Longeveron Inc. | Grant or award | +180,000 | — | — |
| Jul 1, 2025 | Longeveron Inc. | Shares withheld for tax | −13,146 | $1.28 | $16,827 |
| Apr 1, 2025 | Longeveron Inc. | Shares withheld for tax | −13,384 | $1.50 | $20,076 |
| Jan 2, 2025 | Longeveron Inc. | Shares withheld for tax | −10,827 | $1.79 | $19,380 |
| Oct 1, 2024 | Longeveron Inc. | Shares withheld for tax | −13,357 | $1.88 | $25,111 |
| Aug 15, 2024 | Longeveron Inc. | Grant or award | +311,250 | — | — |
| Aug 15, 2024 | Longeveron Inc. | Shares withheld for tax | −39,248 | $2.46 | $96,550 |
| Apr 11, 2024 | Longeveron Inc. | Open-market purchase | +10,638 | $2.35 | $24,999 |
| Mar 12, 2024 | Longeveron Inc. | Grant or award | +80,200 | — | — |
| Mar 12, 2024 | Longeveron Inc. | Shares withheld for tax | −32,866 | $0.54 | $17,748 |
| Jan 2, 2024 | Longeveron Inc. | Shares withheld for tax | −5,123 | $1.32 | $6,762 |
Questions about Mohamed Wa'el Ahmed Hashad
What boards is Mohamed Wa'el Ahmed Hashad on?
Mohamed Wa'el Ahmed Hashad sits on the boards of Akari Therapeutics plc and Longeveron Inc.
What company is Mohamed Wa'el Ahmed Hashad the CEO of?
Mohamed Wa'el Ahmed Hashad is Chief Executive Officer of Longeveron Inc.
How long has Mohamed Wa'el Ahmed Hashad served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.